Key statistics
As of last trade Alzchem Group AG (ACT:BRN) traded at 132.08, -11.64% below its 52-week high of 149.48, set on Jul 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 132.08 |
|---|---|
| High | 132.08 |
| Low | 132.08 |
| Bid | 131.73 |
| Offer | 132.63 |
| Previous close | 132.08 |
| Average volume | 15.00 |
|---|---|
| Shares outstanding | 10.18m |
| Free float | 6.13m |
| P/E (TTM) | 23.61 |
| Market cap | 1.47bn EUR |
| EPS (TTM) | 6.10 EUR |
| Annual div (ADY) | 1.68 CHF |
|---|---|
| Annual div yield (ADY) | 1.27% |
| Div ex-date | May 09 2025 |
| Div pay-date | May 13 2025 |
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Announcements
- EQS-DD: Alzchem Group AG: four two na GmbH, sell
- EQS-News: Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
- EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-Adhoc: Alzchem Group AG: Alzchem Group AG Resolves Share Buyback of up to 10 Million Euros
- EQS-News: Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors
- EQS-Adhoc: Alzchem Group AG: Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products
- EQS-DD: Alzchem Group AG: Andreas Lösler, buy
More ▼
